Hypersensitivity Syndrome - a clinical case report

Authors

  • Sandra Marques Interna do Complementar de Medicina Interna, Serviço 1 de Medicina do Hospital de Curry Cabral, Lisboa
  • F. Aldomiro Assistente Hospitalar de Medicina Interna, Serviço 1 de Medicina do Hospital de Curry Cabral, Lisboa
  • A. Martins Baptista Assistente Hospitalar de Medicina Interna, Serviço 1 de Medicina do Hospital de Curry Cabral, Lisboa
  • M. Helena Pacheco Assistente Hospitalar Graduado de Medicina Interna, Serviço 1 de Medicina do Hospital de Curry Cabral, Lisboa
  • José A. Malhado Assistente Hospitalar Graduado de Medicina Interna, Serviço 1 de Medicina do Hospital de Curry Cabral, Lisboa

Keywords:

hypersensitivity syndrome, captopril, cutaneous lesions, hepatic toxicity

Abstract

Pharmacological therapy results in complications
in approximately 19% of all hospitalised patients and
cutaneous complications are most frequently
encountered (2 to 3%). Although in most cases the
adverse events are mild, they can be serious,
presenting as Stevens-Jonhson Syndrome, toxic
epidermal necrolysis or as a hypersensitivity
syndrome. With respect to the hypersensitivity
syndrome, anti-convulsant and sulphonamides are
the drugs most frequently involved, but several other
drugs have been implicated, including, Captopril.
The authors present the case of a 75-year-old
woman who initiated therapy with Captopril and
presented 4 weeks later with a complicated case.
The patient had fever, skin rash, hepatic failure,
acute renal failure, pneumonitis, pericarditis,
lymphocytosis with atypical lymphocytes, and
eosinophilia. The exuberant presentation was highly
suggestive of hypersensitivity syndrome and the
diagnosis was confirmed following clinical investigation and evolution.

Downloads

Download data is not yet available.

References

Roujeau J, Stern R. Severe adverse cutaneous reactions to drugs. NEJM 1994; 331: 1272 - 1285.

Knowles S, Shapiro L, Shear N. Anticonvulsant hypersensitivity syndrome. Drug Safety 1999; 6: 489 - 501.

Conilleau V, Dompmartin A, Vernevil L et al. Hypersensitivity syndrome due to two anticonvulsant drugs. Contact Dermatitis

; 41 (3): 141-144.

Rodrigues P et al. Síndrome de hipersensibilidade ao alopurinol simulando linfoma cutâneo. Medicina Interna 1997; 4 (3): 182 -

Schatz P, Mesolites D, Hyun J et al. Captopril-induced hypersensitivity lung disease. Ann immune-complex-mediated phenomenon. Chest 1989; 95: 685 - 687.

Shear N. Diagnosing cutaneous adverse reactions to drugs. Arch Dermatol 1990; 126: 94 - 97.

Lynn A et al. Guidelines of care for cutaneous adverse drug reactions. J Am Acad Dermat 1996; 35: 458 - 461.

Fitzpatrick T, Johnson R, Wolff K. Drug hypersensitivity syndrome. Color Atlas and Synopsis of Clinical Dermatology 3ª Ed. 1997 :

- 585.

Antunes A, Davril A, Tréchot P. Syndrome d‘hypersensibilité à la minocycline. Ann Dermatol Venereol 1999; 126: 518 - 521.

Macneil M, Haase D, Tremaine R. Fever, lymphadenopathy, eosinophilia, lymphocitosis, hepatite and dermatitis: a severe

reaction to minocycline. Journal of American Academy of Dermatology 1997; 36: 347 - 350.

Wilkin J, Hammond J, Kirkendall W. The captopril induced eruption, a possible mechanism: cutaneous kinin potentiation.

Arch Dermatol 1980; 116: 902-905.

Pederson K. Adverse reaction in the skin from anti-hypertensive drugs. Dan Med Bull 1987; 34 (1): 3-5.

Magro C, Crowson A. Drug-induced immune dyregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis. Hum Pathol 1996; 27(2): 125 - 132.

Roujeau JC. Treatment of severe drug eruptions. J. Dermatol 1999; 26 (11): 718-722

Additional Files

Published

2001-09-28

How to Cite

1.
Marques S, Aldomiro F, Martins Baptista A, Pacheco MH, Malhado JA. Hypersensitivity Syndrome - a clinical case report. RPMI [Internet]. 2001 Sep. 28 [cited 2024 Nov. 21];8(3):129-31. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/1907

Issue

Section

Case Reports

Most read articles by the same author(s)